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ABSTRACT OF DISSERTATION

CHARACTERIZING THE ROLE OF GLUCOCORTICOIDS IN THE SIGN TRACKING
BEHAVIOR OF MALE JAPANESE QUAIL (COTURNIX JAPONICA)
A devastating feature of drug-dependence is the susceptibility of relapse (40-60%)
after stretches of abstinence. One theory that may account for relapse suggests that drug cues
(e.g., paraphernalia) may increase stress hormones, and this may prompt relapse. Repeatedly
pairing a neutral cue with a reward is commonly utilized to measure what subjects learn
about a cue that is predictive of reward. Research has shown that animals that attend to a cue
more than to the reward (sign trackers) may be more vulnerable to drug addiction.
Additionally, research has shown that sign tracking is associated with an increase in
corticosterone (CORT), a primary stress hormone. PT 150 is a novel glucocorticoid receptor
antagonist that attenuates the effects of CORT. Experiment 1 hypothesized that subjects
given repeated oral administration of 40 mg/kg PT 150 would reduce sign tracking compared
to subjects given placebo. Results of Experiment 1 showed that repeated oral consumption of
40 mg/kg PT 150 decreased sign tracking behavior compared to placebo. In Experiment 2, it
was hypothesized that PT 150 (20/40/60 mg/kg) given by subcutaneous (SC) injection would
reduce sign tracking dose-dependently, and that sign tracking behavior would correlate with
CORT levels. Results of Experiment 2 showed that SC injection of 20 mg/kg PT 150 reduced
sign tracking but not 40 or 60 mg/kg. Additionally, the correlation between CORT and the
sign tracking for the 20 mg/kg approached significance. Although tentative, the correlation
may suggest that elevated plasma CORT concentrations correlate with elevated sign tracking.
The current findings extend the current literature by suggesting that the glucocorticoid
receptor may be a potential pharmacological target for reducing relapse-like behaviors.
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Chapter One
INTRODUCTION
The economic cost of illicit drug use in the United States (US) is estimated in the
billions (NIDA, 2017). These costs include loss of productivity, increased healthcare, and
criminal justice expenses. Additionally, users spend billions per year on illegal substances
like heroin and cocaine. An average of 21.5 million Americans are battling drug dependence
(NIDA, 2014). Alarmingly, the highest at risk for dependence are youths, with early abuse
starting at 12 to 13 years of age (NIDA, 2014). It is estimated that 1 in 12 youths is suffering
from a dependence use disorder. Among the individuals that seek treatment, 40-60% relapse,
depending on the substance (NIDA, 2014). Because of the alarming rate of relapse, drug
dependence is characterized as a chronic, relapsing disease (Leshner, 1997).
It is widely accepted that visual cues in the environment may become associated with
drug taking and subsequently, in the absence of drug, cause drug-seeking and ultimately
relapse (Childress et al., 1999). Cues (items, places or people) associated with a drug may
trigger relapse (Lee, Milton & Everitt, 2006; Saunders & Robinson, 2013; Meyer, Ma &
Robinson, 2012). In recent studies with human participants, it has been demonstrated that
cues associated with drugs of reward, prompt drug-seeking behaviors (Wang, Shi, Chen, Xu,
Li, Sun & Lu, 2013). Specifically, studies investigating cocaine cues established that subjects
experience increased craving in response to cocaine-related cues (Fox et al., 2012). In animal
models, it has been reliably demonstrated that cues paired with drugs of reward may initiate
renewed drug-seeking behavior (Loweth, Tseng & Wol 2013; Pratt & Ford, 2013; Fischer,
Houston & Rebec, 2013; Gipson, Khoo, Gibson, Prasad & McNally, 2017). Collectively,
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these experiments suggest that cue-induced relapse may be one of the underlying problems
with drug dependence.
Incentive Salience
The theory of incentive salience postulates that cues associated with rewards may bias
attention towards those cues and motivate reward seeking (Morrow, Maren & Robinson,
2011; Robinson & Berridge, 1993). When cues that come to elicit approach through
conditioning “become attractive” and motivate actions, they are said to have acquired
incentive salience (e.g., Meyer, Cogan & Robinson, 2014; Saunders & Robinson, 2013;
Robinson & Berridge, 2008). Research conducted with rodents indicates that there are
individual differences in the propensity to attribute incentive salience to reward paired cues.
For example, when a localizable cue (conditioned stimulus, i.e., CS) becomes associated with
the receipt of food reward, for some rodents (sign trackers; STs), the cue itself becomes
attractive, eliciting approach and engagement with it (Hearst & Jenkins, 1974). For these
rodents, the CS also serves as a potent conditioned reinforcer (i.e., STs will work to get it;
Flagel, Akil & Robinson, 2009; Robinson & Flagel, 2009). For other rodents (goal trackers;
GTs), the cue is equally predictive of reward (i.e., it serves as an effective CS), but they
instead learn to approach the location of reward delivery, and for these rodents the CS is
relatively ineffective as a conditioned reinforcer (Robinson & Flagel, 2009; Yager &
Robinson, 2010).
The attribution of incentive salience to an addiction-relevant stimulus (CS) is thought
to be responsible for a CS’s ability to reinstate drug-seeking behaviors after bouts of
abstinence (e.g., Everitt & Robbins, 2000; Kruzich, Congleton & See, 2001). One possible
reason for this theory is that when a person is in the presence of cues that have acquired
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incentive salience, they may experience stress, which subsequently instigates renewed drug
seeking (i.e., relapse). This may happen because a cue that has acquired incentive salience
may activate the brain’s reward circuitry, which overlaps with the brain’s stress pathway
(Cobb & Thiel, 1982; Robinson & Berridge, 1993; Kreek & Koob, 1998). For example,
individuals with drug dependency show increased cortisol plasma concentrations (Wilkins,
Gorelick & Nademanee, 1982; Wand & Dobs, 1991; Mello & Mendelson, 1997), display
increased drug taking that is correlated with elevated stress, and report stress as a cause for
relapse (Jacobsen, Southwick & Kosten, 2001). In rodents, a stimulus repeatedly paired with
a reward increases plasma corticosterone concentrations (Tomie, Silbberman, Williams &
Pohorecky, 2002; Tomie, Tirado & Pohorecky, 2004). Specifically, increases were higher in
sign-tracking rodents when compared to goal-tracking rodents (Flagel, Watson, Akil &
Robinson, 2008; Tomie, Lincks, Nadarajah, Pohorecky & Yu, 2012). Thus, it is hypothesized
that corticosterone contributes to the rewarding effects of drugs and that addiction-relevant
cues facilitate stress-like changes in plasma corticosterone concentrations. Therefore,
corticosterone may serve as a relatively new therapeutic target for cue-induced relapse
because of the potential interactions between stress and cues that have acquired incentive
salience.
Hypothalamic-pituitary-adrenal axis (HPA)
The HPA has significant involvement in stress and reward (Tomie, Grimes,
Pohorecky, 2008). In sign tracking, it is hypothesized that reward-predicting cues activate the
HPA axis which stimulates the hypothalamus (Flagel et al., 2008). The hypothalamus when
stimulated releases a hormone, corticotrophin releasing factor (CRF) (Peeters, Ruist,
Craighead & Kitchner, 2008). CRF in turns signals to the pituitary gland to release
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adrenocorticotrophic hormones (ACTH) into the bloodstream (Iverson, Iverson, Bloom &
Roth, 2009). ACTH travels in the bloodstream to the adrenal glands where it stimulates the
release of glucocorticoids. The release of glucocorticoids is a self-regulating system, in that
as levels of glucocorticoids increase, a built-in feedback mechanism shuts off CRF.
Specifically, this feedback system turns CRF off when the steroid receptors in the
hypothalamus register excess glucocorticoids (Ivesron et al., 2009). In rodents, the
predominant glucocorticoid is corticosterone (CORT), and it is released following the
activation of the HPA axis (Raubenheimer, Young, Andrew & Seckle, 2006).
CORT, Glutamatergic Plasticity, and Sign tracking
Sign tracking is a possible behavioral consequence of associative learning resulting
from Pavlovian conditioning (Beckmann & Chow, 2015). Research has shown that
glutamatergic receptors (i.e., AMPA) increase in response to Pavlovian conditioning (Mead
& Stephans, 2003).Learning involves glutamatergic plasticity resulting from the transmission
of glutamate receptors (e.g., NMDA and AMPA) that have critical roles in long-term
potentiation (LTP), (Mead & Stephans, 2003). LTP is a strengthening of synaptic plasticity
as a result of learning (Rioult-Pedotti, Friedman & Donoghue, 2000). Because sign tracking
is a learned phenomenon and has been associated with increased CORT (Flagel et al., 2008),
it is possible that increased sign tracking is the result of CORTs enhancement of
glutamatergic plasticity (Calandreau et al., 2011).
Glucocorticoid Receptor (GR) antagonists
Glucocorticoids such as CORT exert their effect by binding to the GR (Peeters et al.,
2008). When CORT binds to the GR, the GR forms a GR-CORT complex that enters the
nucleus and exerts its effects by the transcription of new genes. GR antagonists block
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glucocorticoids from binding to the GR, thus reducing the effect of CORT. The natural
hormone CORT is not specific for the GRs (Peeters et al., 2004). For example, traditional
antagonists of the GR (RU 486) also act on progesterone receptors (Vegeto et al., 1992). The
affinity of RU 486 for the progesterone receptor can result in pregnancy termination. As a
result, RU 486 is not a viable treatment option for half the population (i.e., females). Finding
alternatives to RU 486 is a significant research endeavor because of CORT’s role in
metabolic disorders and addiction (Arnaldi et al., 2003; Sinha & Jastreboff, 2013).
The GR antagonist, 11, 21-Bisphenyl-19-norpregnane derivative (PT 150) is a novel
antagonistic that competes with CORT for GR binding in the cytoplasm (Peters et al., 2008).
When PT 150 binds to the GR, the GR inhibitory complex is not dislocated. Therefore, the
signaling cascade stops and CORT’s effects cannot be realized. Most importantly, PT 150
has a 6-fold lower affinity for the progesterone receptor when compared to RU 486, making
it a useful alternative (Peeters et al., 2004). In addiction research, PT 150 attenuated ethanolincreased plasma CORT in rodents (Reynolds et al., 2015). For these reasons, PT 150 may
be of value in addiction research in that it can attenuate the effects of CORT without
affecting the progesterone receptor.
Avian Model of Sign tracking
It is widely accepted that visual cues in the environment (e.g., paraphernalia, drug
taking confederates, and places) may become associated with drug taking and later, in the
absence of drug, renew drug-seeking behaviors and ultimately lead to relapse (e.g., Childress,
et al., 1999; Carter & Tiffany, 1999). Because of the ability of visual cues to reinstate drug
taking, birds extend the study of sign tracking, as they are primarily visual, whereas rodents
largely depend on olfaction (Johnson & Whittow, 2000; Crombag, Badiani, Maren &
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Robinson, 2000). Specifically, Japanese quail are a visually oriented bird species with color
vision and high visual acuity (Mills, Crawford, Domjan & Faure, 1997). The study of sign
tracking can benefit from an animal model that has a similar visual system to that of humans.
Importantly, sign and goal tracking behaviors have already been identified in quail (e.g.,
Burns & Domjan, 1996; 2000; 2001).
In humans, the diurnal rhythm of plasma stress hormones (i.e., cortisol) peak in the
morning and slowly declines into the night (Cauter, Leproul & Kupper, 1996). Similar to
rodents, the bird’s predominant glucocorticoid is corticosterone (CORT) (Ellestad, Puckett &
Porter, 2015). Birds, including Japanese quail, have a similar diurnal rhythm of plasma
CORT, where plasma CORT increases at the start of darkness, with a maximum CORT
concentration at first light (Kovack, 1983; Joseph & Meier, 1972). Conversely, rodent’s
diurnal rhythm is the opposite, with the lowest point of plasma CORT concentration being at
first light (the inactive period for these nocturnal animals) and the peak at the onset of
darkness (the active period) (Ulrich-Lai, Arnold & Engleland, 2005). Because studies of sign
tracking with rodents are conducted in the day, when their CORT is the lowest, this may
make quail a better translational model when studying stress hormone effects, in that the
diurnal rhythm of CORT in quail may be more representative of humans.
The Current Experiments
The overall goal of the present research was to attenuate sign tracking by reducing the
effect of CORT. To assess the effect of CORT on sign tracking, PT 150 was administered
after the acquisition of sign tracking in male quail. We hypothesized that repeated
administration of PT 150 would decrease sign tracking compared to placebo. Moreover, it
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was hypothesized that PT 150 would dose-dependently decrease sign tracking compared to
placebo.
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Chapter Two
A GLUCOCORTICOID RECEPTOR ANTAGONIST REDUCES SIGN-TRACKING
BEHAVIOR IN MALE JAPANESE QUAIL
(Rice B.A., Eaton S.E., Prendergast M.A. & Akins C.K., 2018)
Decades of substance abuse research have demonstrated the parallels between drug
addiction behaviors and behaviors elicited from Pavlovian conditioning (for review,
Anselme, 2016; Lamb, Schindler & Pinkston, 2016). For example, in Pavlovian conditioning,
environmental cues that become associated with a reward come to elicit approach to the cue
following conditioning. When these cues become attractive and motivate actions, they are
said to have acquired incentive salience (Meyer, Cogan & Robinson, 2014; Saunders &
Robinson, 2013; Robinson & Berridge, 2008). Research conducted with rodents indicates
that there are individual differences in the propensity to attribute incentive salience to cues
that become associated with reward. For example, when a localizable cue (conditioned
stimulus, i.e. CS) becomes associated with the receipt of food reward, for some rodents (sign
trackers; STs), the cue itself becomes attractive, eliciting approach and engagement with it
(Hearst & Jenkins, 1974). For STs, the CS also serves as a potent conditioned reinforcer
(Flagel, Akil & Robinson, 2009; Robinson & Flagel, 2009). For other rodents (goal trackers;
GTs), the cue is equally predictive of reward (i.e., it serves as an effective CS), but they
instead learn to approach the location of reward delivery, and for these rodents the CS is
relatively ineffective as a conditioned reinforcer (Robinson & Flagel, 2009; Yager &
Robinson, 2010).
The identification of animals that have the propensity to sign track is important
because attribution of incentive salience to cues is associated with addictive behavior. In rats,
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STs that attribute incentive salience to a cue are more likely to self-administer cocaine
compared to GTs (Beckmann, Marusich, Gipson & Bardo, 2011). Additionally, STs show
greater cocaine-induced behavioral sensitization (Flagel et al., 2008), a greater cocaineinduced conditioned place preference (Meyer, Ma, & Robinson, 2012), and have more robust
rates of reinstatement to drug-paired cues compared to GTs (Saunders & Robinson, 2010).
Overall, these studies show that STs may be more vulnerable to drug addiction.
In rodents, high levels of corticosterone (CORT), a predominant stress hormone,
correlate with the propensity to sign track (e.g., Flagel et al., 2008). Additionally, the
presentation of a CS that predicts reward increases CORT (Tomie, Silbberman, Williams, &
Pohorecky, 2002; Tomie, Toreadp, Yu, & Pohorecky, 2004) and this increase is greater in
sign tracking rodents that attribute incentive salience to the cue when compared to subjects
that do not sign track (i.e., goal trackers) (Flagel et al., 2008). These findings suggest that
CORT may be a potential target for reducing sign tracking behaviors.
It is widely accepted that visual cues in the environment may become associated with
drug taking and subsequently, in the absence of drug, cause drug-seeking and ultimately
relapse (Childress et al., 1999). Therefore, studying substance abuse with an avian species
may be of an additional benefit because birds are primarily visual whereas most rodents
largely depend on olfaction (Carsia & Harvey, 2000; Crombag, Badiani, Maren & Robinson,
2000). Japanese quail are a visually-oriented bird species with color vision and high visual
acuity (Mills, Crawford, Domjan & Faure, 1997). Numerous drug studies have been
conducted with Japanese quail (Levens & Akins, 2004; Geary & Akins, 2007; Akins &
Geary 2008; Bolin & Akins, 2012; Gill, Rice & Akins, 2015; Gill, Madison & Akins, 2015).
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These studies demonstrate that the drug responses in quail are largely conserved relative to
rodents.
The HPA axis involves an auto-regulated feedback system that includes 2 types of
adrenal steroid receptors, the glucocorticoid receptor (GR) and the mineralocorticoid receptor
(MR) (Bachmann, Linthorst, Holsboer & Reul, 2003). This dual receptor system is
responsible for homeostasis of the HPA axis. GR antagonists (e.g., PT 150) have been shown
to increase MR expression (Bachmann et al., 2003). When the MR/GR balance shifts toward
an increase in MRs, there is a decreased corticosterone response to stress (de Kloet, 1991).
Therefore, PT 150 may be a potential target for reducing the stress hormone corticosterone.
11, 21-Bisphenyl-19-norpregnane derivative (PT 150) is a GR antagonist that
competes with the binding of CORT in the cytoplasm (Peeters, Ruigt, Craighead &
Kitchener, 2008). A similar compound to PT 150 is RU 486 which is a methylenedioxy
phenyl analog of PT 150 (Peeters et al., 2008). However, in addition to competing with the
GR, RU 486 modulates the progesterone receptor (PR) (Gagne, Pons & Philibert, 1985). The
compound PT 150 is a novel compound in that, unlike RU 486, PT 150 has minimal effect on
the progesterone receptor (PR). PT 150 has a 500-fold greater affinity for the GR while RU
486 has a 5.4-fold affinity for the GR over the PR (Gebhard, Van Der Voort, Schuts &
Schoonen., 1994).
In the current study, we used a Pavlovian conditioning paradigm that measures
individual differences in acquired incentive salience to cues that become associated with
reward (Domjan, Lyons, North & Bruell, 1986; Beckmann & Bardo, 2012; Flagel et al., 08).
To assess the ability of a GR antagonist to attenuate sign tracking, PT 150 was administered
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after acquisition of sign tracking in male quail. We hypothesized that PT 150 would decrease
sign tracking compared to placebo following repeated administration.
Methods
Subjects
Twenty-two (N = 22) adult male Japanese quail (Coturnix japonica) were hatched
from eggs (Georgia Quail Farm (GQF), Savannah, GA) and were raised in mixed sex groups
until approximately 6 weeks of age. Quail were housed in individual wire mesh cages
(supplied by GQF Manufacturing, Savannah, GA) and maintained on a 16:8 hr light cycle. At
10 months of age, twenty-two male quail were randomly assigned to one of 2 groups (drug or
placebo; ns = 11). The number of subjects per group was chosen based on a power analysis
using Gpower (Faul & Erdfelder, 1992; Erdfelder, Faul & Buchner, 1996) with power set at
0.80, an effect size at 0.50, and α = 0.05 for two tailed F tests.
All experimental procedures were conducted according to the guidelines of the
Institutional Animal Care and Use Committee (IACUC) at the University of Kentucky and
by the standards outlined in the 8th edition of the Guide for the Care and Use of Laboratory
Animals (National Research Council, 2010). These entities adhere to the standards of the
APA ethical standards for treatment of animals.
Glucocorticoid receptor antagonist (PT 150)
The study was designed to ensure that birds would voluntarily consume PT 150
because forced administration (e.g. gavage in liquid vehicle) might have induced stress.
Thus, a solid vehicle that birds found highly palatable, peanut butter, was used to assure
consumption of the drug. Use of highly palatable solid foods (e.g., Peanut butter and Nutella)
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are a common means of assuring voluntary oral consumption of pharmacological substances
(Goldkuhl, Hau & Abelson, 2010; Berger & deCatanzaro, 2007; Cope et al., 2005).
Capsules containing drug (150 mg) or placebo were opened and added to Peanut
Butter (PB) (150 mg/2g). The mixture was measured out at 0.53 mg/kg, resulting in a 40
mg/kg dose, and was given orally one hour before Pavlovian conditioning on days 11-15. As
a control measure, 0.53 mg/kg of PB was provided on Pavlovian conditioning days 1-10.
The dose of PT 150 was chosen based on previous research with rodents (Sharrett-Field,
2013).
Apparatus
Behavioral testing was conducted in a standard conditioning chamber (Med
Associates Inc., Georgia, VT; 22 cm × 19 cm × 13 cm) that had an acrylic hinged loading
door, stainless steel side panels, and an acrylic back panel. The chamber was located in a
sound- and light-attenuating cabinet equipped with a fan that provided continuous
ventilation. A white noise generator provided low-level background noise, and a white house
light provided illumination. Two key lights (red and green) were mounted at one end of the
chamber 12.7 cm above the metal rod floor, and a food magazine (ENV-205m MED
Associates) was located between the key lights. The key lights and food magazine were
illuminated with LED lights when activated.
Procedures
Food restriction
During Pavlovian conditioning, food restriction was used to ensure motivation of
reward (i.e., grain). Male quail were maintained at 85% body weight, where food was
available from 3 PM to 6 PM daily. This body weight matches previously defined avian
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methods of food deprivation (Duval, Cassey, Miksik, Reynolds & Spencer, 2013a; Duval et
al., 2013b; Shousha, Nakahara, Nasu, Sakamoto & Murakami, 2007). Quail were weighed
daily, and following the establishment of their mean free-feeding body weight, 18% of their
mean body weight was calculated to provide minimum caloric intake in grams of feed to
sustain 85% body weight throughout conditioning (e.g., Lejeune & Nagy, 1986).
Conditioning
A Pavlovian-conditioned approach (PCA) procedure was used to measure the
attribution of incentive salience to a CS. Before conditioning, birds were shaped with
successive approximation until they reliably retrieved grain from the hopper. Shaping was
followed by 15 days of Pavlovian conditioning. During conditioning, each trial was
composed of presentation of an 8-sec green key light (CS+) followed by immediate 8-sec
access to grain (unconditioned stimulus, US) in a food hopper. The pairing of the CS and US
was on a variable time interval (VT) of 90 sec resulting in an average of a 30 min session. An
8-sec red key light (CS-) was presented unpaired with the US and used as a control, and thus
was not predictive of food. Twenty trials were conducted each day for 15 days for a sum of
300 trials each for CS+ and CS-. Time spent near the CS to both key lights was measured
during CS presentation on days 6, 10, 11, and 15. Day 6 was chosen because previous
studies have shown that sign tracking is evident by trial 125 of conditioning (e.g., Flagel et
al., 2008) which corresponds to day 6 in the current experiment. Day 10 was the last day
before PT 150 was administered, day 11 was the first day PT 150 was administered, and day
15 was the last day PT 150 was administered.
Time spent near the CS was scored when subjects had both feet inside the zone (15.24
cm x 7.62 cm) marked off in front of the CS light and were oriented toward the CS. Goal
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tracking was scored as time spent near the food hopper when subjects had both feet inside of
the zone (15.24 cm x 8.89 cm) marked off in front of the hopper. Video recordings were
scored by visual observation. Researchers scoring the videos were blind to the treatment
condition of the subjects.
Statistical Analysis
Sign and goal tracking
Repeated-measures ANOVAs were conducted with treatment as a between-subjects
factor and day (collapsed across trials) as a repeated measure to investigate changes in sign
tracking to the CS+ and the CS-. A repeated-measures ANOVA with treatment as a betweensubjects factor was conducted for day 10 (the last day before treatment) and day 15 (the last
day of treatment) to determine the effects of repeated PT 150 administration. A posthoc
analysis was conducted on day 15 to examine changes in sign tracking as a result of
treatment. To determine the behavioral specificity of PT 150, a repeated-measures ANOVA
with treatment as a between--subjects factor was conducted on goal tracking for days 10 and
15.
Response bias
A response bias analysis was used to determine the relative amounts of sign and goal
tracking and then to investigate whether drug effects were the same regardless of extent of
sign tracking. A similar response bias analysis has been used in previous research (e.g.,
Meyer et al., 2012; Paolone, Angelakos, Meyer, Robinson & Sarter, 2013). Response bias
was defined as the difference between time spent near the food hopper and the CS+ light
during CS+ presentation. The calculation was expressed as [(time spent at CS+ minus time
spent at hopper) / (time spent at CS+ plus time spent at hopper)]. Quail were considered to be
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expressing a response bias of sign tracking if they obtained scores ranging from +0.4 to +1.0
and were considered to have a response bias of goal tracking if they obtained scores ranging
from -0.4 to -1.0. Quail with intermediate scores (ITs) were not considered to be showing a
response bias of either sign or goal tracking. The response bias analysis was conducted on
day 10 because it was the last day before treatment.
Difference score
To evaluate the change in sign tracking across days 10 and 15 in relation to the extent
of sign tracking (response bias), a difference score was calculated as time spent near the CS+
on day 15 minus time spent sign tracking on day 10 during the CS+ presentation. A positive
difference score indicated increased sign tracking from day 10 to day 15, while a negative
score difference indicated decreased sign tracking from day 10 to day 15.
To determine whether PT 150 had a similar effect regardless of the extent of sign
tracking, the relationship between the response bias and the difference score was analyzed
with a Pearson’s r correlation with treatment as a factor.
For all statistical analyses, alpha was set at p < 0.05.
Results
Figure 1.1A shows mean sign tracking across days (1, 6, 10 and 15) for each
treatment group. A repeated-measures ANOVA revealed a main effect of Day [F(3, 60) =
12.25, p < 0.05], demonstrating that sign tracking (time spent at CS+) increased over
conditioning days, regardless of treatment. There was no significant Day x Treatment
interaction [F(3, 60) = 2.24], nor a main effect of Treatment [F(1, 20) = 2.6], ps > 0.05.
The repeated-measures ANOVA conducted to investigate the effect of PT 150 on sign
tracking behavior on day 10 and 15 revealed a Day x Treatment interaction [F(1, 20) = 5.68]
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and a main effect of Treatment, [F(1, 20) = 5.93], ps < 0.05. A posthoc analysis indicated a
significant main effect of Treatment on day 15 [F(1, 20) =5.42, p < 0.05]. Subjects that
received PT 150 (M = 3.35, SEM = 0.3) spent significantly less time sign tracking than
subjects that received the placebo (M = 4.33, SEM = 0.3).
To determine whether PT 150 had an effect on time spent near the CS-, a repeatedmeasures ANOVA was conducted for days 6, 10, 11 and 15 for placebo and drug treatments
(see Figure 1.1B). There was no significant Day x Treatment interaction [F(3, 60) = 2.13],
indicating that treatment groups did not change in time spent near the CS- across days. There
were also no main effects of Treatment or Day, Fs were between 0.38 to 2.13, ps > 0.05.
To explore the individual differences of sign and goal tracking a response bias was
calculated. The analysis showed that 12 out of 22 quail had a response bias toward sign
tracking. Ten out of the 22 quail had neither a sign nor goal tracking response bias.
There was no positive correlation between the difference score and the response bias
(r = 0.52), nor between treatment groups and the response bias (r = 0.06), ns 22, ps > 0.05.
Therefore, the extent of sign tracking did not correlate with the difference score. However,
there was a negative correlation between treatment groups and the difference score.
Treatment with PT 150 was correlated with decreased sign tracking, (r = -0.47, p < 0.05).
Thus, regardless of the extent of sign tracking, sign tracking appeared to be associated with
treatment effects rather than the degree of the response bias.
To investigate the behavioral specificity of PT 150, a repeated-measures ANOVA
was conducted on days 10 and 15 with goal tracking as the dependent variable. Results
showed that there was no main effect of Day [F (1, 20) = 0.30, p > 0.05], indicating that time
spent goal tracking did not change from day 10 to 15. There was also no significant Day x
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Treatment interaction [F(1, 20) = 0.09, p > 0.05], indicating that the drug did not affect goal
tracking. Overall, these results indicate that the behavioral effects of PT 150 may have been
specific to sign tracking.
Discussion
Similar to rodents, the quail in the current experiment demonstrated an increase in
sign tracking toward a cue that had been paired with reward across days (e.g., Flagel, Akil &
Robinson, 2009). Most importantly, repeated oral consumption of PT 150 resulted in a
decrease in sign tracking behavior when compared to placebo. This reduction of sign tracking
may have been the result of PT 150 blocking the glucocorticoid receptor (GR).
Administration of the GR antagonist PT 150 has been shown to reduce CORT in rodents that
consumed alcohol (Reynolds et al., 2015). This reduction in CORT was thought to occur
because PT 150 inhibits the nuclear translocation of the GR that indirectly regulates the
release of CORT (Peeters et al., 2008). While the findings of the current experiment suggest
that reduced sign tracking may have been a result of a blockade of the GR, it is unknown
whether the GR is antagonized in the same manner in birds as in rodents.
There are changes in the brain that are related to sign tracking. For example, repeated
activation of the reward pathway results in heightened behavioral responses that have been
determined to be a predictor of drug addiction (Tomie, Grimes & Pohorecky, 2008). The
hypothalamic-pituitary-adrenal (HPA) axis is involved in the activation and management of
stress responses and has been shown to contribute to a heightened reward pathway (Piazza &
Moal, 1998). In Pavlovian conditioning, this heightened response (e.g., elevated pecking,
sniffing, and licking) is often referred to as sign tracking (e.g., Tomie et al., 2008). Similar to
stress, sign tracking also disrupts the hypothalamic-pituitary-adrenal (HPA) axis and this may
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result in alteration of the HPA axis’ negative feedback system, (e.g., Flagel et al., 2008;
Tomie et al., 2008). Therefore, in the current study, the reduction in sign tracking may have
been associated with dysfunction of the HPA axis.
The current study extends previous research by demonstrating reduced sign tracking
as a result of repeated administration of a GR antagonist, suggesting that sign tracking may
be associated with an increase in CORT and mediated via the GR. The link between sign
tracking and CORT is particularly interesting in that CORT could be a biomarker for future
pharmacological treatments in individuals suffering from substance use disorders. However,
further research is needed for validating the reduction of CORT by PT 150 and its
relationship to sign tracking.

Copyright © Beth Ann Rice 2018
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Figure 1.1

Figure 1.1. Mean time (sec) near the CS+ (Figure 1.1A) and CS- (Figure 1.1B) across days 6,
10, 11, and 15 for placebo and drug treatments. * Significant difference between day 10 and
15, + significant difference between treatment groups on day 15.
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Chapter Three
REPEATED BLOCKADE OF THE GLUCOCORTICOID RECEPTOR WITH PT 150
HAS DOSE-DEPENDENT EFFECTS ON SIGN TRACKING IN MALE JAPANESE
QUAIL
In both animal (e.g., Davis & Smith, 1976, de Wit & Stewart, 1981) and human (for
review, Carter & Tiffany, 1999) research, it has been demonstrated that cues (e.g.,
paraphernalia) associated with drug reward can instigate renewed drug taking. These cues
may be items used to consume the drug, and people, and places they take drugs around.
One reason this may occur is that in the presence of these cues, the person experiences a
stress response that prompts the individual to seek out drugs to moderate the stress
response. There are individual differences in response to drug cues. It has been established
that non-human animals that show a stress response to reward-predictive cues exhibit
heightened reward behaviors to cocaine, a psychostimulant (Flagel, Watson, Akil &
Robinson, 2009). As a consequence, these subjects (i.e., Sign trackers, STs) may be more
vulnerable, than subjects that do not sign track to the rewarding effects of drugs. Therefore,
the cooperative interaction between stress and a drug-cue association may be a therapeutic
target for the treatment of cue-induced relapse.
Individual differences in response to drug cues can be measured in traditional animal
models. A Pavlovian conditioned approach (PCA) paradigm, in which a cue predicts a
reward (e.g., sex, drug, and food) is typically used to measure these differences (Domjan,
Lyons, North, Bruel & Bardo, 1986; Beckmann & Bardo, 2012; Flagel et al., 2008). Animals
that spend the majority of the time near a cue that predicts reward (i.e., sign trackers, STs)
have been shown to exhibit higher rates of drug-taking behaviors (Beckman et al., 2012) and
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increased locomotor activity (i.e., sensitization) in response to cocaine (Flagel et al., 2008).
Consequently, STs are thought to be more vulnerable to drug addiction and are utilized as a
model of cue-elicited drug-taking behaviors. Sign tracking behaviors have been
demonstrated with a key light in pigeons (e.g., Brown & Jenkins, 1968, Papini & Overmier,
1984) bobwhite quail (Gardner, 1969), and Japanese quail (Crawford & Domjan 1993). The
behavior exhibited by birds have a corresponding response, similar to the rodent lever press
(i.e., key peck). In previous research, we have measured sign tracking in Japanese quail using
a similar method as rodent models (Rice, Eaton, Prendergast & Akins, 2018).
Sign tracking is associated with elevated stress hormones (Flagel et al., 2009, Tomie
et al., 2002). Previous research has shown that a stress hormone corticosterone (CORT) is
elevated after sign tracking behavior, and administration of CORT increases the expression
of sign tracking (Flagel et al., 2007). Conversely, the removal of the adrenal glands, which
release CORT, reduces the ability of a subject to display sign tracking behavior (Carroll,
Campbell & Heidman, 2001). Together, these studies suggest that stress hormones may
facilitate sign tracking and the interaction of CORT and sign tracking may be a potential
target for pharmacological therapies.
CORT is the primary stress hormone in animals, and its effects are a result of the
activation of the glucocorticoid receptors (GRs). GR antagonist, 11, 21-Bisphenyl-19norpregnane derivative (PT 150) is a novel antagonistic that competes with CORT for GR
receptor binding in the cytoplasm (Peeters et al., 2004). The traditional antagonist of CORT
(RU 486) is not viable for half the population of drug users (i.e., females). Specifically, RU
486 cannot be used in females as it causes pregnancy termination through its action on the
progesterone receptor (Vegeto et al., 1992). Therefore, PT 150 may be a better alternative
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than RU 486 because PT 150 is a pure, competitive antagonist with minimal effect on the
progesterone receptor.
The current study was designed to test three doses of PT 150 to investigate dosedependent effects of PT 150 on sign tracking behavior. To examine the effect of PT 150 on
CORT concentrations, blood was taken before the first day of conditioning and on the first
and last day of PT 150 administration.
Methods
Subjects
Thirty-nine (N = 39) adult male Japanese quail (Coturnix japonica) were hatched
from eggs (Northwest Gamebirds, Kennewick, WA). Quail were raised in mixed-sex groups
until approximately six weeks of age and were housed in individual wire mesh cages
(supplied by GQF Manufacturing, Savannah, GA) and maintained on a 16:8 hr light cycle.
Before the current experiment, male quail were randomly assigned to one of four treatment
groups. Data from one bird were not included because the bird died before completion of
conditioning. Therefore, thirty-eight quail were used as subjects in the analyses of the
experiment.
All experimental procedures were conducted according to the guidelines of the
Institutional Animal Care and Use Committee (IACUC) at the University of Kentucky and
by the standards outlined in the 8th edition of the Guide for the Care and Use of Laboratory
Animals (National Research Council, 2010).
Apparatus
Behavioral testing was conducted in two standard Pavlovian conditioning chambers
(Med Associates Inc., Georgia, VT) that had an acrylic hinged loading door, stainless steel
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side panels, and an acrylic back panel (interior, 30.5 x 24.1 x 21 cm). The chambers were
located in a cabinet equipped with a fan that provided continuous ventilation. The top of the
cabinet was removed to illuminate the apparatus with a white fluorescent light. A white noise
generator provided low-level background noise. Two key lights (red and green) were
mounted at one end of the chamber 12.7 cm above the metal rod floor, and a food hopper was
located between the key lights. The key lights and hopper were illuminated with LED lights
when activated.
Drug
PT 150 was dissolved in 30% dimethyl sulfoxide (DSMO)/70% polyethylene glycol
(PEG) – 300), similar to previously established methods (Johnson, Grant, Ingram & Gartside,
2007). On days 1-5 of the PCA trials, quail received a subcutaneous (SC) injection of vehicle
(DMSO-PEG), 30 min before testing (1mL/kg of body weight). On days 6-10 of testing,
quail received one of four SC injections of PT 150 (20 mg/kg n=9, 40 mg/kg n=10, or 60
mg/kg n=10) or vehicle (1 ml/kg of body weight, n=9). These doses were selected based on
previous rodent literature that used doses ranging from from 20 mg/kg to 60 mg/kg
(Bechmann, Linhurst, Hulsbuer & Reul, 2003; Reyonlds et al., 2015).
Procedures
Experiment 2 was conducted in two replications. Twenty animals were tested in
replication 1 and the remaining 18 in replication 2. Replication 2 followed immediately after
the last conditioning day of replication 1. There were no significant differences between the
two replications (F (3,102) = 1.112, p > 0.05) so the replications were combined for all
analyses.
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Food Restriction
During Pavlovian conditioning, food restriction was used to ensure motivation of
reward (i.e., grain). Male quail were maintained at 85% body mass where grain was provided
2-3 hours after conditioning. The resulting body mass closely matches previously defined
bird methods of food deprivation (Duval et al., 2013a; Duval et al., 2013b; Shousha,
Nakahara, Nasu, Sakamoto & Murakami, 2007). Quail were weighed daily and following
the establishment of their mean free-feeding body weight, 18% of their body weight was
calculated to provide minimum caloric intake in grams of feed to sustain 85% body mass
throughout conditioning (e.g., Lejeune & Nagy, 1986). Remaining grain was removed before
lights would come on the following morning.
Conditioning
Procedures for Pavlovian conditioning were similar to previously conducted research
in our laboratory (Rice et al., 2018) as described in Experiment 1. Additionally, the current
experiment recorded additional measures. Time spent measures (sec) were recorded
automatically in zones (15.24 x 8.89 cm) that were in front of both key lights and a zone
(15.24 x 6.35 cm) that was in front of the hopper. Key pecks and hopper entries with
automated equipment were also recorded. There were a total of ten days comprised of 20
trials a day resulting in 200 trials of conditioning.
Locomotor Activity
Distance traveled (meters) was recorded on day 10 for each treatment group.
Corticosterone Procedures
On days 1, 5, 6 and 10 of conditioning, blood was collected via the wing vein, and
plasma was separated and frozen for later analysis. Those days were chosen to investigate the
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effects of sign tracking (days 1 and 5) and the drug PT 150 (days 6-10) on CORT plasma
concentrations. Because of the diurnal rhythm of quail plasma CORT concentrations, testing
was delayed until 10 AM and ended prior to 6 PM to maximize the natural nadir levels of
CORT. An enzyme immunoassay (EIA) kit (Arbor Assay; K017-H1) was used to analyze
CORT concentrations. This particular kit is well suited for quail, as it has a high sensitivity,
detecting plasma CORT concentrations as low as 0.07 ng/g (Arbor Assay; K017-H1).
Sensitivity is of particular importance as Japanese quail have been reported to have low
baseline CORT concentrations, with CORT concentrations as low as 1ng/g (Hayward,
Satterlee & Wingfield, 2005; Cockrem, Candy, Castille & Sattterlee, 2010).
Statistical Analysis
Automated behavioral analysis
Session events were maintained and collected with Med PC software (ENV013; MED
Associates Inc, St. Albans, VT) and videotaped by ANY-MAZE video tracking software
(San Diego Instruments, San Diego, CA) for sign and goal tracking behavior. All of the
procedures were based on previous rodent and quail studies, (e.g., Meyer et al., 2012;
Beckmann & Bardo, 2012, Rice et al., 2018).
Assessment of sign and goal tracking
Sign tracking was scored as two measures; frequency of pecking on the key light and
time (sec) spent in the key light zones (CS). The pecking response was scored as the
frequency of pecks toward the CS+ or CS- when the CS was activated. Time spent at the CS,
and pecking to the CS, while the CS was on, were added together as the sign tracking
response for both the CS- and the CS+. These scores were added together to better represent
rodent sign tracking measures that include approach to the lever and lever contacts as indices
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of sign tracking behavior, resulting in a single sign tracking score for each CS-US
presentation (e.g., Flagel et al., 2008; Meyer et al., 2012). These indices are thought to be
conditioned responses (CRs) that are similar to appetitive and consummatory responses of
the reward (i.e., food) (Flagel et al., 2008).
Goal tracking was measured as time spent in the zone in front of the hopper during
the CS+. Additionally, hopper entry frequencies were scored during the CS+ presentation.
Time spent at the hopper and hopper entries while the CS+ was activated were added
together as the goal tracking response, similar to sign tracking behavior.
Response Bias
The difference between sign and goal tracking behaviors was calculated as a response
bias, similar to previous measures published in our lab (Rice et al., 2018) and based on
rodent literature (e.g., Flagel et al., 2008, Meyer et al., 2012). The response bias was
calculated as the difference between sign and goal tracking responses during the CS+
presentation. The calculation was expressed as [(Sign tracking – Goal tracking)/ (Sign
tracking + Goal tracking)]. Quail were considered to be expressing a response bias of sign
tracking if they obtained scores ranging from +0.4 to +1.0 because these scores indicate that
sign tracking was more than twice as likely as goal tracking. Quail were considered to have a
response bias of goal tracking if they obtained scores ranging from -0.4 to -1.0. Birds with
intermediate scores (intermediates; ITs) were not considered to be showing a response bias of
either sign or goal tracking.
A repeated-measures ANOVA with treatment as a between-subjects factor was
conducted for day 1 (first day of conditioning), day 5 (the last day before treatment), day 6
(first day of treatment) and day 10 (the last day of treatment), to determine the effects of

26

repeated PT 150 administration on sign and goal tracking behavior. A posthoc analysis was
conducted on day 10 to examine changes in sign tracking as a result of treatment.
CS control
For each subject, sign tracking at both the CS+ and CS- were recorded for all 20 trials
of 4 days (1, 5, 6 and 10). A t-test was used to analyze mean time spent on day 5 for the CS+
versus CS- to ensure CS+ control before administration of treatments. Day 5 was chosen
because it is traditionally utilized for classification of sign tracking in rodent models (e.g.,
Flagel et al., 2008; Meyer et al., 2012; Paolone et al., 2013).
Locomotor Analysis
To investigate the effects of PT 150 on locomotor behavior, a one-way between
subjects ANOVA was conducted to compare the effect of treatment on distance traveled for
day 10.
Corticosterone Analyses
A repeated-measures ANOVA with treatment as a between-subject factor was
conducted for days 1, 5, 6 and 10 to determine treatment effects on plasma CORT
concentrations across days. Individual Pearson’s r correlations were computed to assess the
relationship of the response bias on day 10 and CORT concentrations for each treatment
group.
All statistical analyses were conducted using IBM Statistical Package for the Social
Sciences (SPSS) Version 21 Software (IBM Corporation, 2014).The alpha was set at p < 0.05
for all analyses.
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Results
Figure 2.1 illustrates the mean sign tracking responses for day 5 for all subjects. Day
5 was chosen because it was the last conditioning day before treatment, and day 5 is
traditionally used in rodent models for sign tracking characterization. A paired sample t-test
indicated a significantly greater amount of sign tracking to the CS+ (Mean = 40.7486, SEM =
10.81) compared to the CS- (Mean = 4.20, SEM = 1.00), [t (37) = -3.516, p < 0.05]. These
results demonstrated that quail learned that the CS+ was predictive of reward and not the CS.

Figure 2.2 shows the response bias across days for each treatment group. A repeated-

measures ANOVA revealed a main effect of Day, F (3, 96) = 8.818, p < 0.05, demonstrating
that the response bias changed across days. There was also a significant interaction of Day X
Treatment, F (9, 96) = 3.331, p < 0.05, indicating that the change in the response bias across
days was different depending on treatment. To probe the interaction further, one-way
ANOVAs were conducted to investigate the difference in the response bias between
treatments for each day. There were no treatment differences in the response bias for days 1,
5 or 6, with F’s ranging from .491 to 1.34, p > 0.05. However, there was a treatment
difference in the response bias on day 10, F (3, 36) = 11.334, p < 0.05. Post hoc comparison
of the response bias on day 10, using the Tukey HSD test, indicated that the mean score for
the 20 mg/kg PT 150 group (M = -0.40, SEM = 0.21) was significantly different from
placebo group (M = 0.31, SEM = 0.14), the 40 mg/kg (M = 0.70, SEM = 0.18) and 60 mg/kg
(M = 0.90, SEM = 0.24) PT 150 groups.
In order to analyze whether PT 150 changed sign tracking from day 6 to day 10,
within-subject contrasts were conducted. These analyses revealed that there was a difference
in change of the response bias between treatments from day 6 to day 10, F (3, 32) = 8.256, p
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< 0.05. Post hoc comparison of the response bias across days 6 and 10, using the Tukey HSD
test, indicated that the change in response bias was between the 20 mg/kg PT 150 group and
all other treatment groups, p < 0.05. Additionally, a paired sample t-test for the 20 mg/kg
treatment group for days 6 and day 10 revealed that the 20 mg/kg treatment group switched
from a sign tracking response bias score (M = 0.67, SEM = 0.09) on day 6, to a goal tracking
response bias score (M = -0.40, SEM = 0.21) on day 10, t (8) = 4.348, p < 0.05.
Figure 2.3 shows the plasma CORT concentration across days, a repeated measures
ANOVA indicated a main effect of Day, F (3, 99) = 83.92, p < 0.05, demonstrating that
plasma CORT concentrations (i.e., ng/ml) changed across conditioning days. Pairwise
comparisons revealed significant differences between day 5 (M = 51.18, SEM 4.8) and day 6
(M = 37.70, SEM = 3.80) and between days 5 and 10 (M = 39.427, SEM = 4.26), p < 0.05.
There was no significant Day X Treatment interaction, F (9, 99) = 0.91, nor a main effect of
Treatment, F (1, 33) = 0.40, indicating that the change in CORT across days was not due to
treatment.
Figure 2.4 illustrates the correlation between plasma CORT concentrations and the
response bias for each treatment group. There was no significant association between the
placebo, 40 mg/kg, and 60 mg/kg PT 150 treatment groups and their response biases on day
10; r’s ranged from -0.30 to 0.15, p > 0.05. The correlation between the response bias for the
20 mg/kg group (M = -0.35, SEM = 0.21) and their plasma CORT concentration on day 10
(M = 32.90, SEM = 6.83) was nearly significant, r = 0.67, n = 9, p = .05.
Figure 2.5 shows the mean distance traveled on day 10 for all groups. There was no
significant effect of treatment on distance traveled for day 10 (F(3, 37) = 1.031, p > 0.05),
indicating that the drug did not affect locomotor behavior.
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Discussion
Similar to previous research in rodents, quail showed significant sign tracking after
five days of conditioning (e.g., Flagel et al., 2009; Rice et al., 2018). The steady increase in
sign tracking from the first to last day of conditioning was similar to both rodent (e.g., Flagel,
Akil, & Robinson, 2009) and other quail (Burns & Domjan, 1996; 2000; 2001) models of
sign tracking. The significant increase in sign tracking was specific to the paired CS (CS+),
indicative of robust CS control. Pecking to the CS+ and not the CS- is suggestive of subjects
learning the predictive value of the CS+ (e.g., Tomie, Silberman, Williams & Poherecky,
2002). Additionally, PT 150 did not appear to alter locomotor behavior in the current
experiment. This might further implicate the selective nature of PT 150. The selective nature
of PT 150 may be important in that these results support a reduced likelihood of behavioral
side effects from administration of PT 150.
In the current experiment repeated administrations of PT 150 reduced sign tracking, a
drug addiction-like behavior, at a low dose (20 mg/kg PT 150) but not at 40 mg/kg or a 60
mg/kg dose. The reduction in sign tracking in the 20 mg/kg PT 150 group may have been a
result of reduced CORT binding to the GR receptor. Reducing the effect of CORT has been
shown to attenuate sign tracking behaviors previously in both rodents (Thomas & Papini,
2001) and quail (e.g., Rice et al., 2018). The reduction in CORT’s effects, via the
administration of PT 150, is thought to occur because GR antagonists like PT 150 reduce
CORT’s ability to bind to the GR (Peeters, Ruigt, Craighead & Kitchener, 2008). With
reduced binding to the GR, CORT’s effects may not be actualized.
One possible explanation for why PT 150 did not block sign tracking at the higher
doses (i.e., 40/60 mg/kg PT 150) is that PT 150 may have bound to other receptors such as
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the mineralocorticoid receptor (MR). PT 150 reduces the effects of CORT by blocking
CORTs ability to bind with the GR however, previous research has shown that chronic
treatment of PT 150 enhances MR expression (Bachmann et al., 2003), implicating an
upregulation of MRs. CORT has a higher affinity for MR compared to the GR (Peeters et al.,
2004). Therefore, it is probable that at higher doses of PT 150, there is an upregulation of
MRs where CORT can bind and exert its effects. Therefore, the possibility that CORT was
binding nonspecifically to the MR at higher doses may be the reason that higher doses did
not attenuate sign tracking behavior.
The current study did not show any changes in circulating plasma CORT
concentrations across conditioning days. This conflicts with previously reported rodent sign
tracking literature. Tomie and colleagues reported an increase in CORT in rodents that
received a paired cue when compared to animals that received an unpaired cue (et al., Tirado,
Yu & Pohorecky, 2004). Additionally, an increase in CORT was found in rodents that sign
tracked compared to rodents that did not (Flagel et al., 2008). The difference between the
current results and the rodent studies may be a species difference. However, it is more likely
that the procedures used to obtain plasma for CORT analysis were different and may have
increased stress in the current study. Research has shown that circulating plasma CORT
concentrations increase from blood sampling in as little as 3 min (Romero & Romero, 2002).
In rodent models, the blood was taken quickly by tail nip or trunk blood, immediately after
conditioning (Tomie et al., 2002; 2004; Flagel et al., 2008). In the current study, blood
collection took approximately 5-7 min. The differences in collection techniques may account
for these conflicting results.
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The response bias for the 20 mg/kg PT 150 treatment group exhibited an approaching
significant correlation of the response bias and plasma CORT concentrations on day 10. It
appears there was a trend, where higher sign tracking response biases correlated with higher
plasma CORT concentrations. Conversely, there was a trend of lower levels of plasma CORT
concentrations having a nearly significant association with goal tracking response biases.
These tentative results correspond to research in rodent literature where STs display higher
CORT concentrations compared to GTs (Flagel et al., 2009).
Sign tracking is thought to be a measure of cue-induced relapse. Because relapse is
considered one of the most significant problems in drug dependence, animal models of sign
tracking are important. Therefore, biomarkers for reducing behaviors that are associated with
cue-induced drug relapse may be relevant in addiction research. The current findings extend
previous research by suggesting that the GR may be a potential pharmacological target for
reducing relapse-like behaviors. Further research is needed to identify pharmacologically
relevant doses of PT 150, as well as potential side effects and long-term effects on behavior.
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Figure 2.1

Figure 2.1. Mean sign tracking responses for day 5 for all subjects. * Significant difference in
sign tracking responses to CS+ compared to CS- collapsed across all trials.
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Figure 2.2

Figure 2.2. Mean response bias across days 1, 5, 6 and 10 for placebo, and treatment groups.
* Significant difference between day 1 and 5, 5 and 6, and 6 and 10. + Significant difference
between 20 mg/kg treatment group and placebo, 40 and 60 mg/kg groups on day 10. STing =
sign tracking response bias score, GTing = goal tracking response bias score
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Figure 2.3

Figure 2.3. Mean plasma CORT concentrations (ng/ml) across days 1, 5, 6 and 10 for
placebo, and treatment groups. * Significant difference between days 5 and 6. + Significant
difference between days 5 and 10.
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Figure 2.4

Figure 2.4. Correlations between the response bias and plasma corticosterone (CORT)
concentrations (ng/ml), on day 10 for each treatment group. GTing = goal tracking response
bias, STing = sign tracking response bias
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Figure 2.5

Figure 2.5. Total distance traveled activity (mean meters ± SEM), collapsed across all trials
on day 10 for placebo and treatment groups.
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Chapter Four
GENERAL DISCUSSION
Sign tracking has been shown to be associated with an increase in drug taking
behaviors, (e.g., Beckman & Bardo, 2012; Saunders & Robinson, 2013). For example, sign
trackers learn to self-administer cocaine more quickly (Beckmann, Marusich, Gipson &
Bardo, 2011), express heightened behavioral sensitivity to psychostimulants (Flagel et al.,
2007), and develop more robust rates of reinstatement to drug paired cues (Saunders &
Robinson, 2010) when compared to subjects that do not sign track. For these reasons, sign
tracking is utilized as an animal model of a drug dependence like behavior. Additionally, sign
tracking has been shown to be facilitated by the stress hormone, corticosterone (CORT)
(Campbell & Carroll, 2001; Flagel et al., 2007; Tomie et al., 2002; 2004). The current
experiments aimed to reduce sign tracking with a glucocorticoid receptor (GR) antagonist,
which has been shown to block the behavioral effects of alcohol induced CORT in a rodent
model (Reynolds et al., 2015). In Experiment 1, sign tracking was reduced with an oral
administration of 40 mg/kg of the GR antagonist PT 150. In Experiment 2, sign tracking was
reduced with a subcutaneous (SC) injection of 20 mg/kg PT 150 but not a 40 or 60 mg/kg
dose. Additionally, Experiment 2 investigated the relationship of CORT and sign tracking. In
Experiment 2, there was an approaching significant association between the response bias
and plasma CORT concentrations. This correlation suggests that there may be an assocaion
between higher response biases (sign tracking) and higher plasma CORT concentrations.
This finding, although tentative, is similar to what has been found in rodents (Flagel et al.,
2009).
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Experiments 1 and 2 resulted in differences of PT 150 doses that reduced sign
tracking behavior. These differences may be because of the differences between the two
experiments in administration of PT 150. Experiment 1 used an oral route of administration
and found 40 mg/kg of PT 150 to be effective at reducing sign tracking behavior. Experiment
2 used a SC route of administration and found 20 mg/kg of PT 150 to be effective at reducing
sign tracking and not 40 or 60 mg/kg doses. Routes of administration have a critical role in
the bioavailability of a drug in the body. An oral route of administration undergoes first-pass
metabolism whereby the drug is greatly reduced before reaching circulation (Verma, Thakur,
Deshmukh, Jha & Verma, 2010). Experiment 2 used a SC administration, which absorbs
directly into the blood, thus bypassing first-pass metabolism (Verma et al., 2010). SC
administration likely has a higher bioavailability if compared to the bioavailability of an oral
route of administration. This possible increased bioavailability may be why the lower dose
(20 mg/kg) reduced sign tracking behavior in the 2nd Experiment.
Another potential reason for the difference between the doses that reduced sign
tracking between experiments may be because birds have a crop. The function of the crop is
to store ingested feed (Kierończyk et al., 2016) and not a place of digestion (Savory, 1985).
Typically, feed bypasses the crop when feed is readily available. However, when food is
scarce, quail will store feed in their crop. Feed was restricted in both experiments, thus it is
likely that quail stored feed in their crops. Consequently, it is probable that the bioavailability
of an orally administered dose of 40 mg/kg PT 150 was affected by both the crop and first
pass metabolism.
There were differences in sign tracking behavior across conditioning days within
some treatment groups between the two experiments. In Experiment 1, all groups exhibited a
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steady increase in sign tracking across conditioning days. However, in Experiment 2, two
groups (placebo and 40 mg/kg PT 150) exhibited fluctuating sign tracking behavior. These
differences may be because of different characterizations of sign tracking utilized between
the two experiments. In Experiment 1, sign tracking was recorded, as orientation to the CS+
and time spent in the CS+ zone. In Experiment 2, sign tracking was recorded as a response
bias that took into consideration pecking behavior, time spent in the CS+ zone, and goal
tracking behavior. It is possible that orientation to the CS in Experiment 1 inflated the
characterization of sign tracking. Additionally, it is possible that pecking measures, taken in
Experiment 2, fluctuate more than time spent behaviors. However, the fluctuation of sign
tracking seen in Experiment 2 is more likely a result of the response bias taking into account
goal tracking behaviors. Subsequently, the differences in sign tracking behavior across
conditioning days between the two experiments are likely due to these dissimilarities in how
sign tracking was recorded.
Similar to rodents, birds have demonstrated individual differences in sign and goal
tracking (Burns & Domjan, 2001; Flagel et al., 2008). However, in the current experiments,
birds exhibited robust sign tracking behavior and little or no goal tracking behavior after
conditioning and before treatment. These differences may be due to differences in the cues
between our model (key light) and those of rodent (lever) and other quail research (wood
block) (Burns & Domjan, 2001; Flagel et al., 2008). The salience of a cue has long been
shown to effect the conditioned responding to a cue (e.g., Kamin, 1965). Therefore, it is
likely that in the current experiments, quail had heightened salience to the cue (key light),
when compared to previous models that used levers or wood blocks. Because quail rely on
visual cues (Johnson & Whittow, 2000) and rodents rely primarily on olfactory cues
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(Crombag, Badiani, Maren & Robinson, 2000), visual cues may be more salient to quail
when compared to levers in rodent models, and this may be facilitating increased salience to
the cue. Increased salience of a cue has been shown to increase sign tracking behaviors
(Robinson & Berridge, 2008).
The current research is the first research to our knowledge to explore the effects of PT
150 on sign tracking, an addiction-like behavior. The main findings from these studies are
that the GR receptor antagonist PT 150 reduces sign tracking behavior dose-dependently.
Novel pharmaceutical interventions such as PT 150 may reduce the effects of corticosterone
in the presence of addiction-relevant stimuli that may instigate relapse. Future research is
needed to investigate a therapeutic dose and the long-term effectiveness of PT 150 on sign
tracking behavior.

Copyright © Beth Ann Rice 2018
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